Page last updated: 2024-08-23

phosphotyrosine and Blast Phase

phosphotyrosine has been researched along with Blast Phase in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, KI; Bleijerveld, OB; Corradini, E; Heck, AJ; Kolch, W; Müller, PJ; Preisinger, C; Scholten, A; Schwarz, JP1
Bühring, HJ; Busch, FW; Handgretinger, R; Jallal, B; Ludwig, WD; Sures, I; Ullrich, A; Waller, HD; Weiss, FU1
Arlinghaus, RB; Gallick, GE; Gutterman, JU; Keating, MJ; Kloetzer, WS; Kouttab, NM; Kurzrock, R; Maxwell, SA; Parsons, SJ; Talpaz, M1
Foulkes, JG; Frackelton, AR; Huhn, RD; Posner, MR; Rayter, SI1
Nawata, H; Nishimura, J; Shibata, K; Takahira, H1

Other Studies

5 other study(ies) available for phosphotyrosine and Blast Phase

ArticleYear
Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells.
    Leukemia, 2013, Volume: 27, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Benzamides; Blast Crisis; Cell Membrane; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunoprecipitation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphorylation; Phosphotyrosine; Piperazines; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured; Tyrosine

2013
The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
    Blood, 1995, Sep-01, Volume: 86, Issue:5

    Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD34; B-Lymphocyte Subsets; Biomarkers, Tumor; Blast Crisis; Bone Marrow; Cell Line; Cell Separation; Flow Cytometry; Fluorescent Antibody Technique; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Phosphotyrosine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Tyrosine

1995
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Cancer research, 1987, Mar-15, Volume: 47, Issue:6

    Topics: Amino Acids; Antigen-Antibody Complex; Blast Crisis; Cell Line; Humans; Leukemia, Myeloid; Molecular Weight; Peptide Mapping; Philadelphia Chromosome; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Tyrosine

1987
Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.
    Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:13

    Topics: Amino Acid Sequence; Blast Crisis; Blood Proteins; Cell Line; Fusion Proteins, bcr-abl; Humans; Leukemia, Myeloid; Leukocytes; Neoplasm Proteins; Peptide Mapping; Phosphoproteins; Phosphorylation; Phosphotyrosine; Recombinant Fusion Proteins; Recombinant Proteins; Tyrosine

1987
Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique.
    Leukemia, 1989, Volume: 3, Issue:9

    Topics: Blast Crisis; Blotting, Western; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Weight; Neoplasm Proteins; Neutrophils; Peptide Hydrolases; Phosphoprotein Phosphatases; Phosphoproteins; Phosphotyrosine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Tyrosine

1989